Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.73 |
| ▸ | MAOB | P27338 | 1/20 | 0.73 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.70 |
| ▸ | FBP1 | P09467 | 1/20 | 0.63 |
| ▸ | VCP | P55072 | 1/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.62 |
| ▸ | MITF | O75030 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.60 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.59 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.59 |
| ▸ | ITGAL | P20701 | 1/20 | 0.59 |
| ▸ | TGM2 | P21980 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-Nitro-Cinnamic Acid SCHEMBL426380 | 1.00 | MAPT (0.73) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL3290556 | 1.00 | MAPT (0.73) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL29626695 | 1.00 | MAPT (0.73) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL4179178 | 1.00 | MAPT (0.73) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL7990710 | 0.98 | MAPT (0.71) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL27877632 | 0.98 | MAPT (0.71) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL7401665 | 0.98 | MAPT (0.71) | MAPTMAOBNFE2L2FBP1VCP | |
| 3-Nitro-Cinnamic Acid SCHEMBL7990708 | 0.97 | MAPT (0.69) | MAPTMAOBNFE2L2FBP1VCP | |
| SCHEMBL5209312 | 0.91 | MAPT (0.62) | MAPTMAOBNFE2L2FBP1VCP | |
| SCHEMBL5209309 | 0.91 | MAPT (0.62) | MAPTMAOBNFE2L2FBP1VCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 549 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118754842-A | Tryptophan derivative and preparation method and application thereof | 中国人民解放军北部战区总医院 | 2024-10-11 | — | — | CN | claimed |
| CN-115029849-B | Multifunctional warm-keeping knitted fabric and preparation method thereof | 泉州禾伦织造有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-114478256-B | Preparation method of novel curcumin derivative and application of novel curcumin derivative in liver cancer resistance | 安徽理工大学环境友好材料与职业健康研究院(芜湖) | 2024-02-23 | — | — | CN | claimed |
| CN-114014905-B | Glycyrrhetinic acid derivative targeting PPARgamma as well as preparation method and application thereof | 浙江科技学院 | 2023-07-21 | — | — | CN | claimed |
| CN-115537194-A | Ligand modified quantum dot, quantum dot film, preparation method of quantum dot film and light-emitting device | TCL科技集团股份有限公司 | 2022-12-30 | — | — | CN | claimed |
| CN-115029849-A | Multifunctional warm-keeping knitted fabric and preparation method thereof | 泉州禾伦织造有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-113024573-A | Epodophyllotoxin derivative, preparation method and application thereof in preparation of antitumor drugs | 江苏百奥信康医药科技有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-20190256459-A1 | NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2019-08-22 | — | — | US | claimed |
| WO-2017199264-A1 | NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2017-11-23 | — | — | WO | claimed |
| EP-1526584-B1 | Method of forming electroluminescent semiconducting nanocrystal patterned layer for an organic-inorganic hybrid electroluminescent devices, and organic-inorganic hybrid electroluminescent device using the same. | SAMSUNG ELECTRONICS CO LTD (KR) | 2017-06-14 | — | — | EP | claimed |
| US-20050161666-A1 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-07-28 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | LUMINIDE | 2005-04-14 | — | — | US | claimed |
| US-5830999-A | CARBOXYLIC LIGANDS, HEXAMERS | REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-11-03 | — | — | US | claimed |
| US-5376503-A | A photo-crosslinkable blends consisting of an isoolefin, a para-alkylstyrene and a photoinitiator substituted on the alkyl group of para-alkylstyrene monomers; corrosion, solvent resistance | EXXON CHEMICAL PATENTS INC. (US) | 1994-12-27 | — | — | US | claimed |
| EP-0563271-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1993-10-06 | — | — | EP | claimed |
| EP-0563251-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR LITHOGRAPHIC AND CORROSION-RESISTANT COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1993-10-06 | — | — | EP | claimed |
| WO-1992011322-A2 | UV/EB CURABLE BUTYL COPOLYMERS FOR LITHOGRAPHIC AND CORROSION-RESISTANT COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-09 | — | — | WO | claimed |
| WO-1992011295-A1 | UV/EB CURABLE BUTYL COPOLYMERS FOR COATING APPLICATIONS | EXXON CHEMICAL PATENTS INC. (US) | 1992-07-09 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080260-A1 | Preparation of prodrugs for selective drug delivery | APEH, PAH, ALAD | MAPT 2279/4885MAOB 70/4885NFE2L2 1468/4885 |
| US-20190256459-A1 | NOVEL PROCESS FOR THE PREPARATION OF BELINOSTAT | ACR, AADAC, CDK11A | MAPT 3904/4885MAOB 3164/4885NFE2L2 4402/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | MAPT 539/4885MAOB 1285/4885NFE2L2 3435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.